Navigation Links
Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Date:9/8/2008

Paradoxically, many of the common treatment regimens for type 2 diabetes actually cause weight gain.

Treatment with liraglutide in LEAD(TM) 4 also led to a statistically significant decrease in blood pressure as seen in three of the other LEAD(TM) studies: reductions of 6.71 mmHg and 5.65 mmHg with liraglutide 1.2 mg and 1.8 mg, respectively, were observed compared to a decrease of 1.11 mmHg in the comparator group.

Beta cell function, as assessed by multiple parameters (HOMA, C-peptide and proinsulin to insulin ratio), was also significantly improved in subjects who received liraglutide versus the comparator group. Beta cell function is an important measure of disease progression in type 2 diabetes.

LEAD(TM) 4 is the last of the five phase 3a LEAD(TM) (Liraglutide Effect and Action in Diabetes) studies to be presented.

"The complete LEAD(TM) clinical trials program provides convincing evidence that liraglutide represents an effective new treatment approach for type 2 diabetes," said Dr. Bernard Zinman, Professor of Medicine, University of Toronto and Director of the Diabetes Centre Mount Sinai Hospital, Toronto, Canada. "In this clinical trial program, liraglutide offers effective glucose lowering as monotherapy or as an add on to other oral antidiabetic therapies while also consistently lowering weight and blood pressure and enhancing beta-cell function."

About the study

The LEAD(TM) 4 study was a 26-week randomized trial that compared the efficacy and safety of two different doses of liraglutide (1.2 mg and 1.8 mg, QD) to placebo, all added to metformin 2 g (1 g, BID) and rosiglitazone 8 mg (4 mg, BID). The trial included 533 subjects with a mean age of 55.1 years, mean body mass index of 33.5 kg/m2, and mean HbA1c of 8.3. All subjects were previously treated with one or more OADs and received run-in rosiglitazone and metformin therapy before being randomized to liraglutide or placebo.


'/>"/>

SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)...  Ochsner Health System today announced the contract ... medication safety by simplifying and standardizing the medication ... The CareFusion Pyxis ® ES platform ... helps hospitals significantly reduce time for nursing and ... simpler, more efficient workflows. The system also eliminates ...
(Date:6/17/2013)... June 17, 2013  AbbVie (NYSE: ... Phase I study of ABT-199/GDC-0199, an investigational BCL-2 ... high-risk relapsed/refractory chronic lymphocytic leukemia (CLL), and in ... patients are those with deletions of chromosome 17p ... These data were presented at the 18 th ...
(Date:6/17/2013)... , June 17, 2013 Johnson & ... a definitive agreement to acquire Aragon Pharmaceuticals, Inc., ... on drugs to treat hormonally-driven cancers. ... program.  Aragon,s lead product candidate is a second ... 2 development for castration resistant prostate cancer (CRPC). ...
Breaking Medicine Technology:Ochsner Health System Improves Safety Through Advanced Medication Management Technology 2Ochsner Health System Improves Safety Through Advanced Medication Management Technology 3Ochsner Health System Improves Safety Through Advanced Medication Management Technology 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 5AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 2AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 3AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 4AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 5AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting 6Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 3
... Data Continue to Highlight Potential of NeoVista,s ... Epiretinal Brachytherapy, ... from the company,s Phase II feasibility study,examining its novel epiretinal brachytherapy ... the 41st Scientific Meeting of,the Retina Society. The long-term data from ...
... to improve healthcare,system in the Democratic Republic of ... The Clinton Global,Initiative recognized BD (Becton, Dickinson and ... technology company, for its commitment to the,Dikembe Mutombo ... worker safety at the Biamba Marie Mutombo Hospital ...
Cached Medicine Technology:NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 2NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 3NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 4Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
(Date:6/17/2013)... The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer’s dementia, ... journal Radiology. , “Findings of MTBI bear a ... said the study’s lead author, Saeed Fakhran, M.D., assistant ... the University of Pittsburgh School of Medicine. “Additional research ...
(Date:6/17/2013)... 18, 2013 Essential tremor (ET) is ... estimated 10 million people in the United States, and ... clear understanding what causes ET, there are no medications ... cure. Tulips for Tremor© is the International Essential Tremor ... of and a cure for this life-altering neurological condition. ...
(Date:6/17/2013)... BROOK, Ill. The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer,s dementia, ... journal Radiology . , "Findings of MTBI ... Alzheimer,s dementia," said the study,s lead author, Saeed Fakhran, ... Neuroradiology at the University of Pittsburgh School of Medicine. ...
(Date:6/17/2013)... Daimer Industries, Inc.®, a well-renowned U.S. based ... as expertly designed carpet steam cleaner and vapor steam ... for apartment dwellers and homeowners. The commercial steam cleaner ... and pressure levels up to 75 psi to clean ... to clean carpet spots and areas in homes, but ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Nearly 26 ... as many as 79 million adults are estimated to ... to prevent type 2 diabetes through weight loss and ... can help bring your blood sugar level back within ... and factors, 101 Medical Weight Loss physicians can help ...
Breaking Medicine News(10 mins):Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4
... heart surgery fare better if they receive reconstituted blood ... ,Investigators say that children who received reconstituted blood -- ... plasma -- tended to accumulate less fluid, which leads ... researchers compared results for 200 infants who underwent heart ...
... research shows consuming large quantities of alcohol may increase ... ,Researchers studied more than 47,000 men and women. Participants ... and what type of alcohol they consumed. It was ... grams of alcohol each day, while the women consumed ...
... treating benign tumors outside the brain using the CyberKnife ... progression with minimal toxicity. CyberKnife is a non-invasive robotic ... without open surgery. It uses a robotic arm, controlled ... radiation directly to the tumor site. ,During ...
... shows that a common class of drugs used for acute ... to treat.// ,Researchers studied the use of bronchodilators known ... relieve acute asthma attacks. The drugs come in many forms ... pill or liquid form, delivered in a nebulizer, or given ...
... when they are diagnosed with early-stage breast cancer are at ... normal weight.// ,Studies in the past have shown that ... has also shown to have contradictory results about the influence ... researchers say, they have demonstrated a significant association between obesity ...
... known to cause cognitive and behavioral changes in diabetics, ... blood sugar // has a similar effect. ... cognitive functioning and experience deterioration in mood when their ... blood sugar levels due to insulin deficiencies. Patients often ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: